Thomas Stankovich, Chief Financial Officer at ReShape Lifesciences Inc. (RSLS), sold 96,732 shares at $2.89 ($280K) on 2021-09-10, disclosed to the SEC on 2021-09-17.
Open-market sale of $280k RSLS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.89 | 48,366 | $140K | 50.0% |
| 2 | $2.89 | 48,366 | $140K | 50.0% |
| Total | $2.89 avg | 96,732 | $280K | 100% |
| Filing → |
| RSLS | SELL | 2023-07-19 | $156 | — | Filing → |
| RSLS | SELL | 2023-07-06 | $746 | — | Filing → |
| RSLS | BUY | 2023-07-06 | $27K | — | Filing → |